The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Polymer therapeutics as nanomedicines: new perspectives
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Self-citationEvidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Keefe, A. D., Pai, S., & Ellington, A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3141 · Cited by 2,289
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Self-citationNanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Self-citationDavis, M. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900015y · Cited by 977
Greco, F., & Vicent, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.006 · Cited by 652
Dendritic Polyglycerols for Biomedical Applications
Calderón, M., Quadir, M. A., Sharma, S. K., & Haag, R. (2010) · Advanced Materials · doi:10.1002/adma.200902144 · Cited by 629
Preclinical and clinical studies of anticancer agent‐incorporating polymer micelles
Matsumura, Y., & Kataoka, K. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01103.x · Cited by 501
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
Schellenberger, V., Wang, C.-W., Geething, N. C., Spink, B. J., Campbell, A., To, W., Scholle, M. D., Yin, Y., Yao, Y., Bogin, O., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1588 · Cited by 462
Barz, M., Luxenhofer, R., Zentel, R., & Vicent, M. J. (2011) · Polymer Chemistry · doi:10.1039/c0py00406e · Cited by 418
Feldman, E. J., Lancet, J. E., Kolitz, J. E., Ritchie, E. K., Roboz, G. J., List, A. F., Allen, S. L., Asatiani, E., Mayer, L. D., Swenson, C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5961 · Cited by 310
Gaspar, R., & Duncan, R. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.003 · Cited by 304
Self-citationSeymour (2009) · International Journal of Oncology · doi:10.3892/ijo_00000293 · Cited by 304
Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models
Thompson, C. B., Shepard, H. M., O'Connor, P. M., Kadhim, S., Jiang, P., Osgood, R. J., Bookbinder, L. H., Li, X., Sugarman, B. J., Connor, R. J., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0470 · Cited by 298
RNAi‐based therapeutics–current status, challenges and prospects
Tiemann, K., & Rossi, J. J. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900023 · Cited by 283
Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation
Dernedde, J., Rausch, A., Weinhart, M., Enders, S., Tauber, R., Licha, K., Schirner, M., Zügel, U., von Bonin, A., & Haag, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003103107 · Cited by 271
PEGylated Protein Drugs: Basic Science and Clinical Applications
(2009) · doi:10.1007/978-3-7643-8679-5 · Cited by 241
Lammers, T., Subr, V., Ulbrich, K., Peschke, P., Huber, P. E., Hennink, W. E., & Storm, G. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.040 · Cited by 240
Polymer Therapeutics Designed for a Combination Therapy of Hormone‐Dependent Cancer
Vicent, M. J., Greco, F., Nicholson, R. I., Paul, A., Griffiths, P. C., & Duncan, R. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200462960 · Cited by 199
Self-citationWebster, R., Elliott, V., Park, B. K., Walker, D., Hankin, M., & Taupin, P. (2009) · PEGylated Protein Drugs: Basic Science and Clinical Applications · doi:10.1007/978-3-7643-8679-5_8 · Cited by 187
Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin
Davis, M. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.005 · Cited by 171
ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic
Nowotnik, D. P., & Cvitkovic, E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.004 · Cited by 167
Self-immolative linkers in polymeric delivery systems
Blencowe, C. A., Russell, A. T., Greco, F., Hayes, W., & Thornthwaite, D. W. (2010) · Polymer Chemistry · doi:10.1039/c0py00324g · Cited by 159
Real-time monitoring of drug release
Weinstain, R., Segal, E., Satchi‐Fainaro, R., & Shabat, D. (2009) · Chemical Communications · doi:10.1039/b919329d · Cited by 144
Dendrimer-Based Contrast Agents for Molecular Imaging
Longmire, M. R., Choyke, P. L., & Kobayashi, H. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608785849021 · Cited by 138
Polymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapy
Lammers, T., Šubr, V., Ulbrich, K., Hennink, W. E., Storm, G., & Kiessling, F. M. (2010) · Nano Today · doi:10.1016/j.nantod.2010.05.001 · Cited by 137
Chipman, S. D., Oldham, F. B., Pezzoni, G., & Singer, J. W. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.4.375 · Cited by 125
Menjoge, A. R., Rinderknecht, A. L., Navath, R. S., Faridnia, M., Kim, C. J., Romero, R. J., Miller, R. K., & Kannan, R. M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.023 · Cited by 124
Targeting Angiogenesis-Dependent Calcified Neoplasms Using Combined Polymer Therapeutics
Segal, E., Pan, H., Ofek, P., Udagawa, T., Kopečková, P., Kopec̆ek, J., & Satchi‐Fainaro, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005233 · Cited by 116
Herth, M. M., Barz, M., Moderegger, D., Allmeroth, M., Jahn, M., Thews, O., Zentel, R., & Rösch, F. (2009) · Biomacromolecules · doi:10.1021/bm8014736 · Cited by 103
Dextrin−Phospholipase A2: Synthesis and Evaluation as a Bioresponsive Anticancer Conjugate
Ferguson, E. L., & Duncan, R. (2009) · Biomacromolecules · doi:10.1021/bm8013022 · Cited by 98
Self-citationDuncan, R., Gilbert, H. R. P., Carbajo, R. J., & Vicent, M. J. (2008) · Biomacromolecules · doi:10.1021/bm701073n · Cited by 93
Self-citationHybrid Polymer Therapeutics Incorporating Bioresponsive, Coiled Coil Peptide Linkers
Apostolovic, B., Deacon, S. P. E., Duncan, R., & Klok, H. (2010) · Biomacromolecules · doi:10.1021/bm901313c · Cited by 77
Self-citationFunctional polymers as therapeutic agents: Concept to market place
Dhal, P. K., Polomoscanik, S. C., Avila, L. Z., Holmes-Farley, S. R., & Miller, R. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.004 · Cited by 76
van (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s13482 · Cited by 75
Pegylated interferons α2a and α2b in the treatment of chronic hepatitis C
Aghemo, A., Rumi, M. G., & Colombo, M. G. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.101 · Cited by 65
Hardwicke, J., Moseley, R., Stephens, P., Harding, K. G., Duncan, R., & Thomas, D. W. (2010) · Molecular Pharmaceutics · doi:10.1021/mp9002656 · Cited by 60
Self-citationPhase I trial of pegylated interferon-α-2b in young patients with plexiform neurofibromas
Jakacki, R. I., Dombi, E., Potter, D. M., Goldman, S., Allen, J. C., Pollack, I. F., & Widemann, B. C. (2011) · Neurology · doi:10.1212/wnl.0b013e318207b031 · Cited by 57
Enzymatically catalyzed HES conjugation using microbial transglutaminase: Proof of feasibility
Besheer, A., Hertel, T. C., Kreßler, J., Mäder, K., & Pietzsch, M. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21675 · Cited by 55
72/74As-labeling of HPMA based polymers for long-term in vivo PET imaging
Herth, M. M., Barz, M., Jahn, M., Zentel, R., & Rösch, F. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.092 · Cited by 47
Harmatz, P., Grady, R. W., Dragsten, P. R., Vichinsky, E. P., Giardina, P. J., Madden, J., Jeng, M., Miller, B., Hanson, G., & Hedlund, B. E. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06651.x · Cited by 41
Neoadjuvant Paclitaxel Poliglumex, Cisplatin, and Radiation for Esophageal Cancer
DiPetrillo, T. A., Suntharalingam, M., Ng, T., et al. (2011) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e318201a126 · Cited by 39
A Nanoconjugate Apaf-1 Inhibitor Protects Mesothelial Cells from Cytokine-Induced Injury
Santamaría, B., Benito‐Martín, A., Ucero, A. C., Aroeira, L. S., Reyero, A., Vicent, M. J., Orzáez, M., Celdrán, Á., Esteban, J., Selgas, R., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006634 · Cited by 38
Multifunctional Synthetic Poly( l -Glutamic Acid)–Based Cancer Therapeutic and Imaging Agents
Melancon, M. P., & Li, C. (2011) · Molecular Imaging · doi:10.2310/7290.2011.00007 · Cited by 36
Phase II study of NKTR-102 in women with platinum-resistant/refractory ovarian cancer.
Vergote, I. B., Micha, J. P., Pippitt, C. H., Rao, G. G., Spitz, D. L., Reed, N. S., Dark, G. G., Garcia, A., Maslyar, D. J., & Rustin, G. J. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.5013 · Cited by 27
Jaspers, K., Versluis, B., Leiner, T., Dijkstra, P., Oostendorp, M., van Golde, J. C., Post, M. J., & Backes, W. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016159 · Cited by 18
Fang, J. Q., Seki, T., Qin, H., Bharate, G. Y., Iyer, A. K., & Maeda, H. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009304 · Cited by 17
Ferenci, P. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.555079 · Cited by 16
Cited by
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
The expanding role of prodrugs in contemporary drug design and development
Rautio, J., Meanwell, N. A., Di, L., & Hageman, M. J. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.46 · Cited by 767
Therapeutic Protein–Polymer Conjugates: Advancing Beyond PEGylation
Pelegri-O’Day, E. M., Lin, E.-W., & Maynard, H. D. (2014) · Journal of the American Chemical Society · doi:10.1021/ja504390x · Cited by 622
Multifunctional dendritic polymers in nanomedicine: opportunities and challenges
Khandare, J., Calderón, M., Dagia, N. M., & Haag, R. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15242d · Cited by 418
Metadata
- Authors
- Duncan, R.
- Venue
- Current Opinion in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 22
- Issue
- 4
- Pages
- 492-501
- ISSN
- 0958-1669 (ISSN-L)
- OpenAlex
- W2065462876
- Cited by
- 254
- References
- 49
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.